Medically-Integrated Oncology Pharmacy Residency Program
An Innovative & Direct Path To A Successful Career in Oncology Pharmacy
The Medically-Integrated Oncology Pharmacy (MIOP) Residency Program provides new pharmacy graduates and practicing pharmacists an exclusive opportunity to engage in a comprehensive 1-year training program designed to prepare participants for a successful career in oncology pharmacy. NCODA is working with cancer centers throughout the United States to provide the framework and accreditation for this residency program.
Texas Oncology
OUR PURPOSE
To help participants gain and develop comprehensive skills and knowledge to treat cancer patients with the highest level of care. Upon completion of this residency program, graduates will be highly committed, lifelong learners that are able to adapt to various oncology practice settings. Graduates will also become empowered healthcare leaders focused on innovating the continuity of cancer care.
WHAT IS A MEDICALLY-INTEGRATED PHARMACY?
A dispensing pharmacy within an oncology center of excellence that promotes a patient-centered, multidisciplinary team approach. It is an outcome-based collaborative and comprehensive model that involves oncology healthcare professionals and other stakeholders who focus on the continuity of coordinated quality care and therapies for cancer patients.
PARTICIPATING PROGRAMS
- Florida Cancer Specialists & Research Institute (Fort Myers, FL)
- Texas Oncology (Dallas/Fort Worth, TX)
- Hematology-Oncology Associates of CNY (Syracuse, NY)
*Additional programs to be announced. One resident will be selected per practice site.
“At Florida Cancer Specialists & Research Institute (FCS), we are at the forefront of oncology care, of which, much pertains to the therapeutics we offer, ranging from those more commonly used to those only available through clinical trials. Providing real-world experience through the NCODA Accredited FCS Pharmacy Residency Program builds on Doctor of Pharmacy education and outcomes while contributing to the development and competency of clinical oncology pharmacists specializing in a medically-integrated oncology practice.”
future leaders in pharmacy
PROGRAM OVERVIEW
The MIOP Residency Program includes 4 specific rotations:
-
- Oral Outpatient Oncology Practice (5 Months)
- IV/Infusion Oncology Practice (5 Months)
- Pharmacy Business/Leadership (2 Months)
- Research (12 Months |Longitudinal | Finding presented at NCODA Spring Forum)
The goals and competencies of each rotation are developed by the rotation preceptors and approved by NCODA’s Residency Review Committee. The activities and projects that each resident is involved in per rotation will be determined by the Rotation Preceptor and resident prior to the rotation start date, in accordance with NCODA’s MIOP Residency Manual.
Hematology-Oncology Associates of CNY
Program Benefits
Candidates
- Direct path to a career in oncology clinical pharmacy
- Innovative streamlined training in Medically-Integrated Oncology Pharmacy
- Comprehensive oncology education and training at top cancer centers
- Flexibility of tailored rotation opportunities
- Publication and presentation opportunities
- Network at oncology conferences
- Collaborate with NCODA’s network of practices
- Competitive salary
CANCER CENTERS
- Establish an accredited residency program at cancer center
- Custom tailored residency accreditation from NCODA
- Access to curated residency applicant pool
- Expand research opportunities
- Leadership development pipeline (resident –> future practice leader)
- Collaborate with NCODA practices on residency opportunities
Application Criteria
- Completion of pharmacy degree (ACPE-accredited pharmacy school)
- Eligible to work in the United States
- Curriculum vitae
- Official transcript(s)
- Letter of intent
- 2 letter of recommendation contacts
- Application essay explaining why you want to pursue this residency (Max: 2,000 words)
Preferred Experience & Qualifications
- Collaborative
- Strong verbal and written communication skills
- Strong interpersonal skills
- Proficient with Microsoft Office
- Self-starter and able to work independently with minimal supervision
- Eligible for current state licensure based on residency location
Residency Timeline
Application Due: 01/28/22
Application Review by NCODA Residency Committee: 01/29/23 – 02/05/23
Interview Period: 02/06/23 – 02/28/23
Selection: 03/01/23 – 04/07/23
Start Date: 6/26/23 – 07/10/23
*Dates are subject to change per program need.
MIOP Residency Program is led by:
Cooper Bailey, PharmD
Associate Manager of Student-Centered Initiatives
Complete the form below to start the application process for the MIOP Residency Program.
*All applications are reviewed by NCODA Residency Review Committee. Candidates selected for the next step will be contacted by February 6, 2023 to continue the residency application process. Applicants can address their LOI to all the practices or address it to the practice they would like to apply for.
RESOURCES
Cost Avoidance Waste Tracker
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
315-655-4640
P.O. Box 468
Cazenovia, NY 13035
